USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Resmed Pty Ltd

USPTO PatentsView assignee record - 800 granted patents across 62 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

800

Total patents granted

CPC technology areas

22.5

Avg claims per patent

+1133%

5-year filing velocity

The verdict

Resmed holds 800 US patents across 62 technology areas, rank #565 of 50,000 tracked assignees.

#565
of 50,000 US assignees by volume: Top 0.1%
by Innovation Score (70.2/100): 22.5
avg claims per patent: +1133%
filing velocity, last 5 yrs

Portfolio overview

Resmed Pty Ltd has been granted 800 US utility patents between 2019 and 2025, placing Resmed Pty Ltd at rank #565 across all assignees tracked by PlainPatent. This portfolio spans 62 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.5 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Resmed Pty Ltd is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Resmed sits between Ut-battelle, Llc (803 patents, rank #561) and Gentex Corporation (790 patents, rank #569) - the closest US assignees by grant volume. The composite Innovation Score of 70.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 740 grants, compared with 60 in the 2015–2019 window, a +1133% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Resmed Pty Ltd's 22.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 62 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Resmed Pty Ltd against peers pursuing similar technology classes.

Ut-battelle

803
Hefei BOE Optoele…

802
B/E Aerospace

801
Fortinet

801
Resmed Pty ◀

800
Wipro

794
Alcon

793
Bally Gaming

792
Gentex

790

What this shows Resmed holds 800 patents at rank #565, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Resmed

By rank, the assignees closest to #565 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Resmed's primary technology class.

Resmed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

70 Top 1% higher than 99% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Resmed Pty Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	60	7.5%
2020	131	16.4%
2021	122	15.3%
2022	161	20.1%
2023	130	16.3%
2024	112	14.0%
2025	84	10.5%

Which technologies does Resmed Pty Ltd patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 682

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 99

A62B - DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING 59

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 37

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 34

F04D - NON-POSITIVE-DISPLACEMENT PUMPS 33

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 28

H05B - ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL 22

G06F - ELECTRIC DIGITAL DATA PROCESSING 18

B29L - INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES 15

F24F - AIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR CURRENTS FOR SCREENING 15

B33Y - ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING 12

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 12

D10B - INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES 11

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 10

Top 15 of 62 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#565

Across all tracked assignees

Innovation Score

70.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Resmed Pty Ltd hold?

Resmed Pty Ltd holds 800 US granted patents filed between 2019 and 2025, spanning 62 technology areas.

What is Resmed Pty Ltd's Innovation Score?

Resmed Pty Ltd has an Innovation Score of 70.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Resmed Pty Ltd focus on?

Resmed Pty Ltd's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 682 patents. The company has filed patents in 62 CPC subclasses total.

Is Resmed Pty Ltd's patent filing rate increasing or decreasing?

Resmed Pty Ltd's recent filing velocity is +1133% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Resmed Pty Ltd's patents?

Resmed Pty Ltd's patents average 22.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Resmed Pty Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Resmed's 800 grants land it in the top 0.1% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Resmed ranks #565 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.